M1032 HCPCS Level II code: Adults currently taking pharmacotherapy for oud
M1032 is the HCPCS code for “Adults currently taking pharmacotherapy for oud” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
M1032Adults currently taking pharmacotherapy for oud
Short description: Adt tkng pharmthry for oud
HCPCS · United States
Medicare details
The indicators CMS publishes with M1032 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Undefined codes
- Added
- Jan 1, 2019
Where M1032 sits
- 1M codesMedical services and quality measures
- 2Active code M1032Adults currently taking pharmacotherapy for oud
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code M1032 mean?
M1032 is the HCPCS code for “Adults currently taking pharmacotherapy for oud” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover M1032?
CMS lists M1032’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside M1032
All M codesM1026Patients who were in hospice at any time during the performance periodM1027Imaging of the head (ct or mri) was obtainedM1028Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtainedM1029Imaging of the head (ct or mri) was not obtained, reason not givenM1030Patients with clinical indications for imaging of the headM1031Patients with no clinical indications for imaging of the headM1033Pharmacotherapy for oud initiated after june 30th of performance periodM1034Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven daysM1035Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatmentM1036Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven daysM1037Patients with a diagnosis of lumbar spine region cancer at the time of the procedureM1038Patients with a diagnosis of lumbar spine region fracture at the time of the procedure